Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Myeloid AEG-1/MTDH drives inflammation and hepatocellular dysfunction in diet-induced steatohepatitis

Raha S., Reghupaty SC., Qu X., Mendoza RG., Farrar D., Ermi AG.

Animal Study, published in J Biol Chem (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Biol Chem (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41448428
PMCID
PMC12818226
DOI
10.1016/j.jbc.2025.111101
Citations
1

Abstract (original English)

Astrocyte elevated gene-1 (AEG-1)/metadherin plays an important role in regulating lipid metabolism and inflammation in hepatocytes and promotes metabolic dysfunction-associated steatohepatitis (MASH). Myeloid cells, such as macrophages, play a key role in regulating inflammation. Here, we investigated the role of AEG-1 in myeloid cells in regulating high fat)/high sugar diet (HF/HSD)-induced MASH. Littermates of myeloid cell-specific AEG-1 knockout mice (AEG-1 ΔMAC ) and AEG-1 floxed mice (AEG-1 fl/fl ) were fed either a control diet or an HF/HSD for 20 weeks. Both male and female AEG-1 ΔMAC mice were significantly protected from MASH development compared with AEG-1 fl/fl mice. In control diet-fed mice, spatial transcriptomics analysis revealed inhibition of hepatic steatosis and development of hepatocellular carcinoma and activation of fatty acid β-oxidation in the periportal and pericentral hepatocytes of AEG-1 ΔMAC livers. Single-cell RNA-Seq, performed in HF/HSD-fed mice, identified a significant decrease in the total number of Kupffer cells in AEG-1 ΔMAC versus AEG-1 fl/fl livers. A marked inhibition of inflammation and fibrosis in Kupffer cells and stellate cells, increased fatty acid β-oxidation in stellate and endothelial cells, and inhibition of proliferation and invasion in the hepatocytes, especially in pericentral hepatocytes, were observed in AEG-1 ΔMAC liver vers

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
LiverHepatocytesMyeloid CellsAnimalsMice, KnockoutMiceCarcinoma, HepatocellularFatty LiverInflammationRNA-Binding Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.